Details for 2017710261

Up to date per 03.04.2026

Actions

Title / Product Name

KOMBINATIONEN VON LSD1-INHIBITOREN ZUR VERWENDUNG BEI DER BEHANDLUNG NEOPLASTISCHER ERKRANKUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017710261

EP Publication Number

3429571

E-Number

1844297

Language

PCT Number

EP17055784

Publication Date

23.01.2019 A

08.10.2025 B1

Registration Date

08.10.2025

AT Publication Date

15.10.2025

Application Date

13.03.2017

Registration Number

Priorities

15.03.2016

201662308529 P

IPC

A61K 31/4745 20060101AFI20231218BHEP

Maximum Duration of Protection

13.03.2037

Owner

Oryzon Genomics, S.A.Carrera de San Jérónimo 15 2nd floor 28014 MadridES

Representative

No representatives present

Inventor

DEMARIO, Markc/o Roche TCRC Inc. East 29th Street Alexandria Center for Life Science New York NY 10016US

PIERCEALL, Williamc/o Roche TCRC Inc. East 29th Street Alexandria Center for Life Science New York NY 10016US

MACK, Fionac/o Roche TCRC Inc. East 29th Street Alexandria Center for Life Science New York NY 10016US

MAES, Tamarac/o Oryzon Genomics S.A. C. Sant Ferran 74 08940 Cornellà de LlobregatES

LUNARDI, Serenac/o Oryzon Genomics S.A. C. Sant Ferran 74 08940 Cornellà de LlobregatES

Information about Fees